|Print This Page Email to a Friend|
Dr. Mark Cleveland, vice president of new product development at Braintree Laboratories Inc. poses for a photo wth Dr. Jack Di Palma (far left), program director of the division of gastroenterology and professor of internal medicine at the University of South Alabama College of Medicine; Margaret Sullivan (second from right), vice president of development and alumni relations at USA; and Racheal Banks, director of health sciences development and alumni relations at USA. Braintree Laboratories Inc. made a donation to the USA College of Medicine in November.
The USA Division of Gastroenterology recently received a $100,000 donation from Braintree Laboratories, Inc., a privately held pharmaceutical company specializing in gastrointestinal products. The donation was presented to Dr. Jack Di Palma, professor of internal medicine at the USA College of Medicine.
Dr. Mark Cleveland, vice president of new product development at Braintree Laboratories, Inc., said the partnership between Braintree Laboratories and the USA College of Medicine has been very successful. “We have been working with Dr. Di Palma since he was in the Air Force, and when he joined USA we followed him there,” he said. “Since then, USA has been involved in many key studies for our products.”
“Because of our close collaborative relationships, Braintree graciously made a capital campaign donation that will be used by the division of gastroenterology to support research and teaching activities,” he said.
Dr. Di Palma said he became involved with Braintree Laboratories in 1982 while researching a new product the company was developing. “This product became GoLYTLEY, which is used for colon cleansing for diagnostic and surgical procedures,” he said. “We have since collaborated in several clinical studies here at USA leading to the development of products such as NuLYTELY, HalfLYTLEY, MiraLax and SuPREP bowel prep kit.”
According to Dr. Cleveland, the cost for conducting pharmaceutical studies is steadily rising, making it difficult for smaller pharmaceutical companies to operate. “Partnering with academic medical institutions is critical for small companies,” he said. “We have found that working with academic institutions such as USA is very valuable.”
Dr. Cleveland said Braintree also values the partnership with USA because of its diverse patient population. “USA Health has a large patient base that can be drawn upon, which is an important factor the FDA looks for,” he said. “USA also does a fantastic job generating interest and recruiting patients to participate in studies.”
Braintree Laboratories is a privately held pharmaceutical company that was founded in 1982 in Braintree, Mass. They currently have four gastrointestinal lavages available in the United States Market. Click here to learn more.
© 2018 USA Health